Alternatives to Gold Standard Diagnostic Tools for Distinguishing "Natural Kinds" on the Autism Spectrum.
Our best autism tools may miss gene-linked mind traits—add targeted questions when a rare mutation is known.
01Research in Context
What this study did
Philippe (2022) wrote a theory paper. He asked: do our best autism tests brush past rare gene forms?
He reviewed ideas, not kids. He argued each rare mutation may bring its own mind and mood style.
The paper says gold tools like ADOS may tag "autism" but miss the fine print tied to each gene.
What they found
The author found no study that looks for mutation-linked mood or thought traits in ASD checks.
He warns that lumping all kids under one label hides clues that guide care and drug choice.
How this fits with other research
Lopata et al. (2017) also bash one-size-fits-all tools. They say face-shape hunts fail when they lack theory; Philippe adds gene theory.
Kremkow et al. (2022) show tablet games can spot autism risk without a doctor. This seems to clash with Philippe’s doubt, but the apps still use the old sign list—his point is we need new items tied to each mutation, not new tech alone.
Diemer et al. (2023) show girls are missed because checklists were built for boys. Philippe widens the gap: even within boys, rare gene types may be missed if we only count social and repetitive cues.
Why it matters
If a child has a known rare gene, add probes for linked mood, sleep, or motor quirks during your ADOS. Note them in the report. This small step moves us toward care that fits the biology, not just the badge.
Get CEUs on This Topic — Free
The ABA Clubhouse has 60+ on-demand CEUs including ethics, supervision, and clinical topics like this one. Plus a new live CEU every Wednesday.
During intake, ask parents if genetic testing found a rare variant; if yes, add five minutes of questions about sleep, mood, or motor oddities listed for that gene.
02At a glance
03Original abstract
Next-generation sequencing techniques have accelerated the discovery of rare mutations responsible for autism spectrum disorder (ASD) in genes involved in a large number of physiological processes, including the control of gene expression, chromatin remodeling, signaling pathways, synaptic scaffolding, neurotransmitter receptors, and lipid metabolism. Genetic diagnosis provides subjects with an explanation of the cause of their disorder. However, it does not, or at least does not yet, shed light on the psychopathological phenomena specific to the individual. It could be hypothesized that each physiological impact of a mutation corresponds to a specific psychopathological phenomenon of ASD, i.e., “a psychopathological natural kind”. We discuss here the difficulties identifying this specificity of underlying psychopathology in individuals with ASD due to a rare mutation with a major effect. A comparison of Newson's pathological demand avoidance and Wing's Asperger's syndrome with Asperger's autistic psychopathy highlights different ways of approaching psychopathological descriptions and diagnosis, by focusing on either common or unusual features. Such a comparison calls into question the principles of clinical research recommended by Falret for characterizing “disease individuality” of ASD due to a rare mutation.
Frontiers in Psychiatry, 2022 · doi:10.3389/fpsyt.2022.862410